S. B. Prusiner, M. R. Scott, S. J. Dearmond, and F. E. Cohen, Prion protein biology. Cell, vol.93, pp.337-348, 1998.

D. W. Colby and S. B. Prusiner, Prions. Cold Spring Harb. Perspect. Biol, vol.3, p.6833, 2011.

G. G. Kovacs and H. Budka, Molecular pathology of human prion diseases, Int. J. Mol. Sci, vol.10, pp.976-999, 2009.

C. S. Jennelle, V. Henaux, G. Wasserberg, B. Thiagarajan, R. E. Rolley et al., Transmission of chronic wasting disease in Wisconsin white-tailed deer: implications for disease spread and management, PLoS One, vol.9, p.91043, 2014.

, Supplemental Material can be

S. Haïk and J. Brandel, Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses, Infect. Genet. Evol, vol.26, pp.303-312, 2014.

B. W. Caughey, A. Dong, K. S. Bhat, D. Ernst, S. F. Hayes et al., Secondary structure analysis of the scrapieassociated protein PrP 27-30 in water by infrared spectroscopy, Biochemistry, vol.30, pp.7672-7680, 1991.

K. M. Pan, M. Baldwin, J. Nguyen, M. Gasset, A. Serban et al., Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins, Proc. Natl. Acad. Sci. USA, vol.90, pp.10962-10966, 1993.

A. Aguzzi, C. Sigurdson, and M. Heikenwaelder, Molecular mechanisms of prion pathogenesis, Annu. Rev. Pathol, vol.3, pp.11-40, 2008.

N. A. Mabbott and B. M. Bradford, The good, the bad, and the ugly of dendritic cells during prion disease, J. Immunol. Res, p.168574, 2015.

M. Vey, S. Pilkuhn, H. Wille, R. Nixon, S. J. Dearmond et al., Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains, Proc. Natl. Acad. Sci. USA, vol.93, pp.14945-14949, 1996.

T. J. Pinheiro, The role of rafts in the fibrillization and aggregation of prions, Chem. Phys. Lipids, vol.141, pp.66-71, 2006.

N. R. Deleault, J. R. Piro, D. J. Walsh, F. Wang, J. Ma et al., Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids, Proc. Natl. Acad. Sci. USA, vol.109, pp.8546-8551, 2012.

K. Tsiroulnikov, Y. Shchutskaya, V. Muronetz, J. Chobert, and T. Haertlé, Phospholipids influence the aggregation of recombinant ovine prions. From rapid extensive aggregation to amyloidogenic conversion, Biochim. Biophys. Acta, vol.1794, pp.506-511, 2009.

J. G. Safar, H. Wille, M. D. Geschwind, C. Deering, D. Latawiec et al., Human prions and plasma lipoproteins, Proc. Natl. Acad. Sci. USA, vol.103, pp.11312-11317, 2006.

X. Jiang, W. Jin, and M. M. Hussain, The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism, Nutr. Metab, vol.9, p.75, 2012.

J. J. Albers, S. Vuletic, and M. C. Cheung, Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism, Biochim. Biophys. Acta, vol.1821, pp.345-357, 2012.

T. Tzotzas, C. Desrumaux, and L. Lagrost, Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor, Obes. Rev, vol.10, pp.403-411, 2009.

S. Qin, K. Kawano, C. Bruce, M. Lin, C. Bisgaier et al., Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins, J. Lipid Res, vol.41, pp.269-276, 2000.

X. C. Jiang, C. Bruce, J. Mar, M. Lin, Y. Ji et al., Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels, J. Clin. Invest, vol.103, pp.907-914, 1999.

X. Jiang, Z. Li, R. Liu, X. P. Yang, M. Pan et al., Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants, J. Biol. Chem, vol.280, pp.18336-18340, 2005.

R. Liu, J. Iqbal, C. Yeang, D. , Q. Wang et al., Phospholipid transfer protein-deficient mice absorb less cholesterol, Arterioscler. Thromb. Vasc. Biol, vol.27, pp.2014-2021, 2007.

C. Yeang, S. Qin, K. Chen, D. , Q. Wang et al., Diet-induced lipid accumulation in phospholipid transfer proteindeficient mice: its atherogenicity and potential mechanism, J. Lipid Res, vol.51, pp.2993-3002, 2010.

G. Paxinos and K. Franklin, Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates, 2012.

T. Imberdis, A. Ayrolles-torro, A. Rodrigues, J. Torrent, M. T. Alvarez-martinez et al., A fluorescent oligothiophene-bis-triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases, Mol. Neurodegener, vol.11, p.11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02000137

G. A. Carlson, D. T. Kingsbury, P. A. Goodman, S. Coleman, S. T. Marshall et al., Linkage of prion protein and scrapie incubation time genes, Cell, vol.46, pp.503-511, 1986.

M. Scott, D. Foster, C. Mirenda, D. Serban, F. Coufal et al., Transgenic mice expressing hamster prion protein produce speciesspecific scrapie infectivity and amyloid plaques, Cell, vol.59, pp.847-857, 1989.

O. Andréoletti, PrP Sc immunohistochemistry, Techniques in Prion, pp.82-96, 2004.

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., Fiji: an open-source platform for biological-image analysis, Nat. Methods, vol.9, pp.676-682, 2012.

A. Ayrolles-torro, T. Imberdis, J. Torrent, K. Toupet, I. V. Baskakov et al., Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity, J. Neurosci, vol.31, pp.14882-14892, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00635922

K. Kawano, S. Qin, C. Vieu, X. Collet, and X. Jiang, Role of hepatic lipase and scavenger receptor BI in clearing phospholipid/ free cholesterol-rich lipoproteins in PLTP-deficient mice, Biochim. Biophys. Acta, vol.1583, pp.133-140, 2002.

C. Desrumaux, H. P-y.-risold, V. Schroeder, D. Deckert, A. Masson et al., Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice, FASEB J, vol.19, pp.296-297, 2005.

C. Desrumaux, A. Pisoni, J. Meunier, V. Deckert, A. Athias et al., Increased amyloid-? peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice, Neuropsychopharmacology, vol.38, pp.817-825, 2013.

C. Zhu, U. S. Herrmann, J. Falsig, I. Abakumova, M. Nuvolone et al., A neuroprotective role for microglia in prion diseases, J. Exp. Med, vol.213, pp.1047-1059, 2016.

N. A. Mabbott and G. G. Macpherson, Prions and their lethal journey to the brain, Nat. Rev. Microbiol, vol.4, pp.201-211, 2006.

P. A. Mcbride, W. J. Schulz-schaeffer, M. Donaldson, M. Bruce, H. Diringer et al., Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves, J. Virol, vol.75, pp.9320-9327, 2001.

N. Hunter, J. Foster, A. Chong, S. Mccutcheon, D. Parnham et al., Transmission of prion diseases by blood transfusion, J. Gen. Virol, vol.83, pp.2897-2905, 2002.

F. Houston, S. Mccutcheon, W. Goldmann, A. Chong, J. Foster et al., Prion diseases are efficiently transmitted by blood transfusion in sheep, Blood, vol.112, pp.4739-4745, 2008.

L. Gregori, N. Mccombie, D. Palmer, P. Birch, S. O. Sowemimo-coker et al., Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood, Lancet, vol.364, pp.529-531, 2004.

L. Gregori, B. C. Lambert, P. V. Gurgel, L. Gheorghiu, P. Edwardson et al., Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands, Transfusion, vol.46, pp.1152-1161, 2006.

C. A. Llewelyn, P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens et al., Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion, Lancet, vol.363, pp.417-421, 2004.

A. H. Peden, M. W. Head, D. L. Ritchie, J. E. Bell, and J. W. Ironside, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, Lancet, vol.364, pp.527-529, 2004.

J. C. Escolà-gil, G. Llaverias, J. Julve, M. Jauhiainen, J. Méndez-gonzález et al., The cholesterol content of Western diets plays a major role in the paradoxical increase in highdensity lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway, Arterioscler. Thromb. Vasc. Biol, vol.31, pp.2493-2499, 2011.

A. Taraboulos, M. Scott, A. Semenov, D. Avrahami, L. Laszlo et al., Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform, J. Cell Biol, vol.129, p.501, 1995.

, Supplemental Material can be

C. Bate, M. Salmona, L. Diomede, and A. Williams, Squalestatin cures prion-infected neurons and protects against prion neurotoxicity, J. Biol. Chem, vol.279, pp.14983-14990, 2004.

V. Campana, D. Sarnataro, C. Fasano, P. Casanova, S. Paladino et al., Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum, J. Cell Sci, vol.119, pp.433-442, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00166615

S. Gilch, C. Kehler, and H. M. Schätzl, The prion protein requires cholesterol for cell surface localization, Mol. Cell. Neurosci, vol.31, pp.346-353, 2006.

L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo, Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice, J. Lipid Res, vol.49, pp.773-781, 2008.

C. Desrumaux, S. Lemaire-ewing, N. Ogier, A. Yessoufou, A. Hammann et al., Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization, Cell. Mol. Immunol, vol.13, pp.795-804, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01430003

V. Deckert, B. Kretz, A. Habbout, K. Raghay, J. Labbé et al., Development of abdominal aortic aneurysm is decreased in mice with plasma phospholipid transfer protein deficiency, Am. J. Pathol, vol.183, pp.975-986, 2013.

A. Schlitt, J. Liu, D. Yan, M. Mondragon-escorpizo, A. J. Norin et al., Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice, Biochim. Biophys. Acta, vol.1733, pp.187-191, 2005.

S. W. Mok, K. M. Thelen, C. Riemer, T. Bamme, S. Gültner et al., Simvastatin prolongs survival times in prion infections of the central nervous system, Biochem. Biophys. Res. Commun, vol.348, pp.697-702, 2006.

Y. Haviv, D. Avrahami, H. Ovadia, T. Ben-hur, R. Gabizon et al., Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin, Arch. Neurol, vol.65, pp.762-775, 2008.

D. C. Hess and S. C. Fagan, Pharmacology and clinical experience with simvastatin, Expert Opin. Pharmacother, vol.2, pp.153-163, 2001.

, Supplemental Material can be